HLMA
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Halma plc is a global group of life-saving technology companies operating across three sectors: Safety, Environmental & Analysis, and Healthcare. The Safety sector includes technologies that protect people and infrastructure, such as fire detection and pipeline inspection. The Environmental & Analysis sector provides solutions for environmental monitoring, water analysis, and treatment. The Healthcare sector offers diagnostic and monitoring technologies, including blood pressure measurement devices. Halma serves customers in multiple countries, with major operations in the UK, Mainland Europe, the USA, and Asia Pacific. The group comprises nearly 50 companies, including Apollo, Minicam Group, and SunTech, which provide specialized products for commercial, industrial, and healthcare applications.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Conglomerates Homepage halma.com
Sector Industrials IR page halma.com/investors
Tags
fire detection, pipeline inspection, water analysis, blood pressure monitoring, environmental monitoring, safety technology, healthcare diagnostics, infrastructure safety, Apollo, Minicam Group, SunTech
Press page —

Metrics

Valuation  
Market cap £ 14.401B
Market cap (USD) $ 19.33B
P/E 38.68
PEG 2.32
P/BV 6.64
P/S 5.58
P/OCF 29.96
P/FCF 33.83
Dividend yield 0.62%
Turnover / mcap —
Returns  
ROE 18.3%
ROI 12.7%
ROIC 13.6%
Profit margin 14.4%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y —
Earnings growth 3y (net profit CAGR) 16.7%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 34.9%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 38.9%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue 2.582B 2.248B 2.034B 1.853B — — — 1.211B 1.076B 961.662M 807.805M 726.134M 676.506M 676.506M — — —
Net profit 372.3M 296.4M 268.8M 234.3M 244.2M 203.3M 184.4M 169.8M 154.228M 129.689M 108.841M 104.001M 106.327M 106.327M 48.8M — —
Free cash flow 425.7M 448.6M 352.2M 229M 212.2M 254.8M — — — — — — — — — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price 40.62 26.19 22.64 19.4 25.35 24.59 — — — — — — — — — — —
Price performance 12m 0.55 0.16 0.17 -0.23 0.03 — — — — — — — — — — — —

Filed figures

Figure Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (GBP) — 268M 325M 411M 461M 486M 601M
↳ YoY growth +21.3% +26.3% +12.2% +5.4% +23.7%
↳ 5y CAGR +17.5%
Borrowings, current (GBP) — 3M 72.5M 1M 300,000 35.6M 48.9M
Borrowings, non-current (GBP) — 322M 288M 677M 712M 704M 757M
Lease liabilities (GBP) — 65M 72.1M 87.9M 83.7M 110M 108M
Cash and deposits (GBP) 105M 131M 157M 169M 142M 313M 143M
Intangible assets (GBP) — 290M 325M 472M 569M 576M 745M
Net debt (borrowings + leases - cash) (GBP) — 259M 276M 598M 654M 536M 770M
Cash flow detail
Operating cash flow (GBP) — 278M 237M 258M 385M 492M 481M
Purchases of property, plant and equipment (GBP) — -22.8M -25.2M -29M -32.8M -43.8M -54.9M
Dividends paid (cash effect) (GBP) — -63.7M -68.7M -73.3M -78.2M -83.8M -89.7M
Share buybacks (cash effect) (GBP) — -16.2M -19.3M -22.3M -21.1M -7.9M -33.5M
Interest paid (cash effect) (GBP) — -10M -8.2M -17.5M -29.6M -28.9M -32.6M
Free cash flow (OCF - PPE - intangibles) (GBP) — 255M 212M 229M 352M 449M 426M
Income detail
Total comprehensive income (GBP) — 104M 317M 279M 221M 232M 365M
Comprehensive income to owners (GBP) — 104M 318M 279M 221M 232M 365M
Reported Jun 23, 2022 Jun 23, 2022 Jun 23, 2022 Jun 22, 2023 Jun 24, 2024 Jun 20, 2025 Jun 24, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Director/PDMR Shareholding Bull 0 Bear 0 Routine
Trading Update Bull 4 Bear 0 Guidance

24 September 2026

Halma, the global group of life-saving technology companies focused on growing a safer, cleaner, healthier future for everyone, every day, today releases its scheduled trading update ahead of its half year end on 30 September 2026.

Strong progress in the first half; full year Adjusted1 EBIT margin2 guidance increased

We have made strong progress in the first half of this financial year, delivering broad-based growth against a backdrop of continued economic, geopolitical and market uncertainty. Our performance reflects the strength of our Sustainable Growth Model, including decades of disciplined choices around the markets we operate in, the companies we acquire and the leaders we trust to run them. It also reflects the autonomy our model gives our talented teams to respond with agility to changes in their markets. Our approach enables us to invest with confidence and to actively manage our portfolio, delivering compounding growth and returns over the long term.

Based on our progress in the year to date and our current expectations for the remainder of the year, we continue to expect low double-digit percentage organic3 constant currency revenue growth for the year as a whole. This guidance includes premium4 growth of approximately five percentage points from our photonics business, implying an organic3 constant currency photonics growth rate of approximately 30%. Adjusted1 EBIT margin2 in the 2027 full year is now expected to be in the range of 23.5% to 24%. This compares to our previous guidance for margin to be in line with the 2026 financial year at around 22.7%5, with the increase reflecting continued good operational delivery and favourable product and portfolio mix across all three sectors, including the positive impact of recent acquisitions and disposals.

This guidance is supported by order intake which remains ahead of both revenue in the year to date and the comparable period last year.

The recent appreciation of Sterling against the US Dollar and Euro, if maintained, is expected to result in a negative currency translation effect on the Group's results6.

Record investment in acquisitions; healthy acquisition pipeline

Our cash generation and robust financial position support continued investment in future growth, both organically and through acquisitions. We have maintained strong M&A momentum, completing six acquisitions in the year to date, investing a record £515m (on a cash- and debt-free maximum total consideration basis7). We continue to have a healthy acquisition pipeline across all three sectors.

We also continue to actively manage our portfolio of global businesses to ensure capital is allocated towards those opportunities with the greatest potential to deliver sustainable growth and returns, while remaining aligned with our purpose of growing a safer, cleaner, healthier future for everyone, every day. Reflecting this disciplined approach, we have completed three disposals in the period, realising approximately £83m, net of disposal costs8.

Half Year Results

The Group’s results for the half year ending 30 September 2026 will be released on 19 November 2026.

For further information, please contact:

**Halma plc

**Marc Ronchetti, Group Chief Executive +44 (0)1494 721 111

Carole Cran, Chief Financial Officer

Melanie Horton, Co-Head of Investor Relations +44 (0) 7554 013 396

Charles King, Co-Head of Investor Relations +44 (0) 7776 685 948

**MHP

**Oliver Hughes / Rachel Farrington / Ollie Hoare +44 (0)7801 894 577 / +44 (0)7817 458 804 / [email protected]

Notes:

1. Adjusted to remove the amortisation and impairment of acquired intangible assets; acquisition items; significant restructuring costs; profit or loss on disposal of operations, and impairment of associates.

2. Adjusted1 EBIT margin is defined as Adjusted1 Earnings before Interest and Taxation from continuing operations expressed as a percentage of revenue from continuing operations.

3. Organic measures exclude the effect of movements in foreign exchange rates on the translation of revenue and Adjusted1 Profit into Sterling, as well as acquisitions in the year following completion and disposals.

4. The photonics premium is determined as the incremental contribution to Group organic3 revenue growth from the photonics business in excess of the Group’s long-term organic3 revenue growth rate of 7%. It captures the portion of Group organic3 revenue growth, expressed in percentage points, that would not have occurred had photonics grown at the Group’s long-term organic3 revenue growth rate.

5. On 15 May 2025, Nuvonic, an Environmental & Analysis Sector company, granted FluidSmile Fluid Tech Ltd (FluidSmile), a longstanding partner in China, an exclusive trademark licence and related manufacturing and distribution rights to sell certain Nuvonic products in China and other agreed southeastern Asian markets, for RMB95m (£9.9m). Nuvonic also acquired a 35% associate interest in FluidSmile for RMB95m on the same date. As a result of these transactions, one-off revenue of £9.9m and Adjusted1 profit of £9.3m were recognised in financial year 2026, which constituted a 30bps increment to Adjusted1 EBIT margin2.

6. Sterling has strengthened in the year relative to the US Dollar and Euro and the currency translation impact on the Group's results for the financial year ended 31 March 2027 is expected to be negative. Based on current exchange rates of Sterling/US Dollar 1:1.35 and Sterling/Euro 1:1.17, we would expect approximately an £8m negative revenue effect and approximately a £2m negative profit effect in the 2027 financial year, compared to the 2026 financial year.

7. Of the six acquisitions made in the year to date, DCR Inspection Systems Ltd and Surgistar Inc were reported in the Group’s 2026 full year results announcement and disclosed in note 32 to our Annual Report and Accounts 2026. Since that time, we have made four further acquisitions (considerations given are all on a cash- and debt-free maximum total consideration basis):

  • itemedical, a provider of digital platforms that integrates patient data in real time from different devices in hospitals, supporting clinical decision-making and workflow efficiency, acquired in June 2026 for €23m (approximately £20m), as a bolt on for SSG;

  • Näslund Medical, a company specialising in fiducial marker technology used to support targeted cancer treatment, acquired in June 2026 for $45m (approximately £34m), as a bolt on for IZI Medical;

  • Dreampath Diagnostics, a provider of automated systems that enable anatomical pathology laboratories to safely and efficiently track, store and manage patient tissue samples, acquired in July 2026 for €279m (approximately £238m); and

  • Pyxis, a specialist provider of water quality monitoring and analysis technology, acquired in September 2026 for $200m (approximately £148m). Following the announcement on 2 September 2026, the acquisition of all three Pyxis companies has completed.

8. Of the three disposals made in the year to date, Labsphere and Cardios were reported in the Group’s 2026 full year results announcement and disclosed in note 32 to our Annual Report and Accounts 2026. In August 2026, we made one further disposal, of NovaBone, for $56m (approximately £42m), net of disposal costs. We currently expect no material gain or loss to be recognised on this disposal.

9. This Trading update is based upon unaudited management accounts information. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

10. A copy of this announcement, together with other information about Halma, may be viewed on our website www.halma.com

.

Media Gallery

Back

BackCareers

Media Gallery

Home | News and stories | Media Gallery

Find a selection of images from across our companies, ranging from Safety to Environmental & Analysis and Healthcare.

Media Gallery

In this section

Filter

  • Safety

  • Environmental & Analysis

  • Healthcare

  • Leadership

Safety

Safety

Download high-res image

Safety

Safety

Download high-res image

Safety

Safety

Download high-res image

Safety

Safety

Play Video

Safety

Safety

Download high-res image

animated svg for hover

Prompts

Halma plc (ticker HLMA), listed in United Kingdom.

ETFs Holding Halma plc

ETF Weight in ETF Shares Market value As of
BKCI 2.96% 81,634 $ 3.884M Jul 31, 2026
VNIE 2.49% 4,429 $ 231.255K Jun 30, 2026
ESIM 1.88% 7,127 $ 338.568K Jul 31, 2026
MTRA 1.03% 30,005 $ 1.431M Jul 31, 2026
FFDI 0.95% 3,880 $ 184.593K Jul 31, 2026
CGIE 0.91% 480,754 $ 22.127M Nov 16, 2026
IGGY 0.91% 825 $ 40.625K Aug 31, 2026
SROI 0.46% 1,824 $ 86.778K Jul 31, 2026
DWMF 0.38% 2,468 $ 128.864K Jun 30, 2026
SEIE 0.33% 72,997 $ 3.811M Jun 30, 2026
NBIE 0.30% 15,426 $ 750.112K Aug 31, 2026
FFGX 0.29% 3,280 $ 156.048K Jul 31, 2026
QUIZ 0.23% 4,266 $ 209.936K Aug 31, 2026
IVSI 0.17% 257 $ 13.411K Jun 30, 2026
JSTC 0.12% 7,626 $ 351.129K Nov 17, 2026
NTSI 0.12% 11,373 $ 593.83K Jun 30, 2026
IQSZ 0.11% 3,991 $ 190.396K Jul 31, 2026
FENI 0.09% 184,145 $ 9.609M Jun 30, 2026
DFSI 0.08% 20,364 $ 947.263K Nov 12, 2026
TIER 0.08% 582 $ 27.806K Jul 31, 2026
UPAR 0.06% 746 $ 34.349K Nov 17, 2026
DFAI 0.05% 199,702 $ 9.289M Nov 12, 2026
RPAR 0.04% 4,813 $ 221.608K Nov 17, 2026
DFIC 0.04% 121,761 $ 5.664M Nov 12, 2026
AVDE 0.03% 141,537 $ 6.458M Nov 16, 2026
DFAX 0.03% 74,254 $ 3.454M Nov 12, 2026
AVSD 0.00% 224 $ 10.221K Nov 16, 2026